Geron Corporation
149 Commonwealth Drive
Menlo Park
California
94025
United States
Tel: 650-473-7700
Fax: 650-473-7750
Website: http://www.geron.com/
Email: info@geron.com
467 articles about Geron Corporation
-
Geron Corporation to Present at 7th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/29/2008
-
Geron Corporation Scientists and Collaborators Demonstrate Activity of Pancreatic Islet-Like Cells Derived From Human Embryonic Stem Cells in Diabetes
10/28/2008
-
Geron Corporation Initiates Clinical Trial of GRN163L in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
10/20/2008
-
Geron Corporation’s GRN163L Sensitizes Resistant Breast Cancer Cells To Trastuzumab In Preclinical Study
10/15/2008
-
Geron Corporation Supports Governor’s Veto of SB1565
10/1/2008
-
Geron Corporation to Present at UBS Warburg Global Life Sciences Conference
9/18/2008
-
Geron Corporation Announces Issuance of U.S. Patent for Cardiomyocytes From Human Embryonic Stem Cells
9/16/2008
-
Geron Corporation to Present at Thomas Weisel Partners Healthcare Conference
9/4/2008
-
Geron Corporation (JOBS), Exeter Life Sciences, Inc. Form Company for Animal Cloning Technologies
8/13/2008
-
Geron Corporation and Exeter Life Sciences, Inc. Merge stART Licensing, Inc. and ViaGen, Inc. to Form Combined Licensing and Operating Company for Animal Cloning Technologies
8/12/2008
-
Geron Corporation Initiates Clinical Trial of GRN163L in Combination with Paclitaxel and Bevacizumab in Patients with Breast Cancer
8/8/2008
-
Geron Corporation Reports 2008 Second Quarter Financial Results and Events
7/31/2008
-
Geron Corporation Presents Data at International Society for Stem Cell Research Showing that its Embryonic Stem Cell Therapeutic for Heart Failure Evades Direct Attack by the Human Immune System
6/12/2008
-
Geron Corporation to Present at Needham & Company Biotechnology and Medical Technology Conference
6/10/2008
-
Geron Corporation Presentations at the American Society of Clinical Oncology 2008 Annual Meeting
6/2/2008
-
StemCell Technologies Inc. Licenses Geron Corporation Intellectual Property for the Development of Media and Matrices for Stem Cell Growth
5/15/2008
-
FDA Places Geron Corporation's GRNOPC1 IND on Clinical Hold
5/15/2008
-
Geron Corporation to Present at Bank of America Health Care Conference
5/12/2008
-
Geron Corporation Human Embryonic Stem Cell Program Awarded UK Grant Funding
5/6/2008
-
Geron Corporation Reports 2008 First Quarter Financial Results
4/30/2008